tradingkey.logo

Genfit SA

GNFT
View Detailed Chart

3.800USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
189.99MMarket Cap
--P/E TTM

Genfit SA

3.800

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.17%

5 Days

-8.21%

1 Month

-1.81%

6 Months

-1.30%

Year to Date

+2.29%

1 Year

-5.47%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts
STRONG BUY
Current Rating
9.100
Target Price
139.47%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Genfit SA
GNFT
7
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Ionis Pharmaceuticals Inc
IONS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(2)
Buy(1)
Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.019
Buy
RSI(14)
45.122
Neutral
STOCH(KDJ)(9,3,3)
37.223
Sell
ATR(14)
0.155
Low Volatility
CCI(14)
-88.409
Neutral
Williams %R
75.922
Sell
TRIX(12,20)
0.141
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
3.996
Sell
MA10
3.985
Sell
MA20
3.872
Sell
MA50
4.008
Sell
MA100
3.867
Sell
MA200
4.068
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.
Ticker SymbolGNFT
CompanyGenfit SA
CEOMr. Pascal Prigent
Websitehttps://www.genfit.fr/
KeyAI